These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 9367832

  • 1. Inhibition of endogenous cardiac phosphatase activity and measurement of sarcoplasmic reticulum calcium uptake: a possible role of phospholamban phosphorylation in the hypertrophied myocardium.
    Boateng S, Seymour AM, Dunn M, Yacoub M, Boheler K.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):701-5. PubMed ID: 9367832
    [Abstract] [Full Text] [Related]

  • 2. Preservation of the in vivo phosphorylation status of phospholamban in the heart: evidence for a site-specific difference in the dephosphorylation of phospholamban.
    Calaghan S, White E, Colyer J.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):701-5. PubMed ID: 9703990
    [Abstract] [Full Text] [Related]

  • 3. Ca2+/calmodulin-dependent phosphorylation of the Ca2+-ATPase, uncoupled from phospholamban, stimulates Ca2+-pumping in native cardiac sarcoplasmic reticulum.
    Xu A, Narayanan N.
    Biochem Biophys Res Commun; 1999 Apr 29; 258(1):66-72. PubMed ID: 10222236
    [Abstract] [Full Text] [Related]

  • 4. Relationship between phospholamban and nucleotide activation of cardiac sarcoplasmic reticulum Ca2+ adenosinetriphosphatase.
    Coll KE, Johnson RG, McKenna E.
    Biochemistry; 1999 Feb 23; 38(8):2444-51. PubMed ID: 10029538
    [Abstract] [Full Text] [Related]

  • 5. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium.
    Münch G, Bölck B, Karczewski P, Schwinger RH.
    J Mol Cell Cardiol; 2002 Mar 23; 34(3):321-34. PubMed ID: 11945024
    [Abstract] [Full Text] [Related]

  • 6. Sub-antihypertensive doses of ramipril normalize sarcoplasmic reticulum calcium ATPase expression and function following cardiac hypertrophy in rats.
    Boateng SY, Seymour AM, Bhutta NS, Dunn MJ, Yacoub MH, Boheler KR.
    J Mol Cell Cardiol; 1998 Dec 23; 30(12):2683-94. PubMed ID: 9990539
    [Abstract] [Full Text] [Related]

  • 7. Ca2+-overload inhibits the cardiac SR Ca2+-calmodulin protein kinase activity.
    Netticadan T, Temsah RM, Kawabata K, Dhalla NS.
    Biochem Biophys Res Commun; 2002 May 03; 293(2):727-32. PubMed ID: 12054530
    [Abstract] [Full Text] [Related]

  • 8. Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.
    Movsesian MA, Colyer J, Wang JH, Krall J.
    J Clin Invest; 1990 May 03; 85(5):1698-702. PubMed ID: 2139670
    [Abstract] [Full Text] [Related]

  • 9. Molecular determinants of altered Ca2+ handling in human chronic atrial fibrillation.
    El-Armouche A, Boknik P, Eschenhagen T, Carrier L, Knaut M, Ravens U, Dobrev D.
    Circulation; 2006 Aug 15; 114(7):670-80. PubMed ID: 16894034
    [Abstract] [Full Text] [Related]

  • 10. Reversal of phospholamban-induced inhibition of cardiac sarcoplasmic reticulum Ca(2+)-ATPase by tannin.
    Chiesi M, Schwaller R.
    Biochem Biophys Res Commun; 1994 Aug 15; 202(3):1668-73. PubMed ID: 8060355
    [Abstract] [Full Text] [Related]

  • 11. Intermolecular conformational coupling and free energy exchange enhance the catalytic efficiency of cardiac muscle SERCA2a following the relief of phospholamban inhibition.
    Mahaney JE, Albers RW, Waggoner JR, Kutchai HC, Froehlich JP.
    Biochemistry; 2005 May 31; 44(21):7713-24. PubMed ID: 15909986
    [Abstract] [Full Text] [Related]

  • 12. Reconstitution of phospholamban--an approach to its function.
    Holtzhauer M, Sydow H.
    Biomed Biochim Acta; 1987 May 31; 46(8-9):S388-92. PubMed ID: 2963626
    [Abstract] [Full Text] [Related]

  • 13. The putative role of phospholamban in the regulation of the heart muscle.
    Holtzhauer M, Sydow H, Levchenko TS.
    Biomed Biochim Acta; 1986 May 31; 45(1-2):S233-6. PubMed ID: 2938576
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of protein phosphatase activities in preparations from failing human hearts.
    Neumann J, Maas R, Bokník P, Jones LR, Zimmermann N, Scholz H.
    J Pharmacol Exp Ther; 1999 Apr 31; 289(1):188-93. PubMed ID: 10087003
    [Abstract] [Full Text] [Related]

  • 15. The sarcoplasmic reticulum proteins are targets for calpain action in the ischemic-reperfused heart.
    Singh RB, Chohan PK, Dhalla NS, Netticadan T.
    J Mol Cell Cardiol; 2004 Jul 31; 37(1):101-10. PubMed ID: 15242740
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes.
    Antipenko AY, Spielman AI, Sassaroli M, Kirchberger MA.
    Biochemistry; 1997 Oct 21; 36(42):12903-10. PubMed ID: 9335549
    [Abstract] [Full Text] [Related]

  • 17. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
    Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM.
    Circ Res; 2005 Dec 09; 97(12):1314-22. PubMed ID: 16269653
    [Abstract] [Full Text] [Related]

  • 18. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
    Dash R, Frank KF, Carr AN, Moravec CS, Kranias EG.
    J Mol Cell Cardiol; 2001 Jul 09; 33(7):1345-53. PubMed ID: 11437540
    [Abstract] [Full Text] [Related]

  • 19. Interactions of 6-gingerol and ellagic acid with the cardiac sarcoplasmic reticulum Ca2+-ATPase.
    Antipenko AY, Spielman AI, Kirchberger MA.
    J Pharmacol Exp Ther; 1999 Jul 09; 290(1):227-34. PubMed ID: 10381780
    [Abstract] [Full Text] [Related]

  • 20. [Alteration of phospholamban phosphatase activity associated with cardiac sarcoplasmic reticulum during sepsis in rats].
    Yang Q, Wu LL, Tang X, Tang CS.
    Sheng Li Xue Bao; 1995 Aug 09; 47(4):357-65. PubMed ID: 7481877
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.